Pancreatic Surgery Unit, Department of Surgery, San Raffaele Scientific Institute, Milan, Italy.
HPB (Oxford). 2014 Jan;16(1):40-5. doi: 10.1111/hpb.12062. Epub 2013 Feb 20.
A relaparotomy for a pancreatic fistula (PF) after a pancreaticoduodenectomy (PD) is a formidable operation, and the appropriate treatment of anastomotic leakage is under debate. The objective of this study was to compare the outcomes of different strategies in managing the pancreatic remnant during a relaparotomy for PF after a PD.
In this retrospective study on prospectively collected data, 669 PD were performed between 2004 and 2011. The study group comprised 31 patients requiring a relaparotomy, because of delayed haemorrhage (n = 19) or sepsis (n = 12). The pancreatic stump was treated either using pancreas-preserving techniques (simple drainage or duct occlusion) or completion of a pancreatectomy (CP). In 2008, autologous islet transplantation (AIT) was introduced for endocrine tissue rescue of CP.
The mortality rate, blood loss and transfusion requirement were similar for all techniques. Patients undergoing a CP required a further relaparotomy less frequently than patients with pancreas preservation (7% versus 59%, P < 0.01), and the intensive care unit (ICU) stay was reduced after CP (P = 0.058). PF persisted at discharge in 66% of patients after pancreas-preserving techniques. AIT was associated with CP in 7 patients, of whom one died post-operatively. Long-term graft function was maintained in four out of six surviving patients, with one insulin-independent patient at 36 months after transplantation.
When a PF requires a relaparotomy, CP has become our favoured technique. AIT can reduce the metabolic impact of the procedure.
胰十二指肠切除术(PD)后因胰瘘(PF)而行再次剖腹手术是一项艰巨的操作,对于吻合口漏的适当治疗仍存在争议。本研究的目的是比较 PD 后 PF 再次剖腹手术时不同处理残胰策略的结果。
在这项前瞻性收集数据的回顾性研究中,2004 年至 2011 年期间共进行了 669 例 PD。研究组包括 31 例因延迟性出血(n=19)或脓毒症(n=12)而需要再次剖腹手术的患者。胰瘘的胰残端采用保留胰腺技术(单纯引流或胰管阻塞)或完成胰切除术(CP)处理。2008 年,引入了自体胰岛移植(AIT)以拯救 CP 后的内分泌组织。
所有技术的死亡率、出血量和输血需求相似。行 CP 的患者再次剖腹手术的频率明显低于行胰腺保留技术的患者(7%比 59%,P<0.01),CP 后 ICU 住院时间缩短(P=0.058)。行胰腺保留技术的患者出院时 PF 持续存在的比例为 66%。AIT 与 7 例 CP 相关,其中 1 例术后死亡。6 例存活患者中有 4 例长期维持移植物功能,移植后 36 个月时 1 例患者无需胰岛素。
当 PF 需要再次剖腹手术时,CP 已成为我们首选的技术。AIT 可以减少手术的代谢影响。